AVITA MEDICAL INC (RCEL) Stock News
NASDAQ:RCEL - Nasdaq - US05380C1027 - Common Stock - Currency: USD
RCEL Latest News, Press Relases and Analysis
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
Largest real-world RECELL study shows 6.2-day shorter hospital stays and $300 million in savings, presented at BBA 2025....
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™
AVITA Medical announces the first clinical publication of Cohealyx, demonstrating significantly faster wound bed vascularization and autograft readiness....
AVITA Medical Reports First Quarter 2025 Financial Results
AVITA Medical reported financial results for the first quarter 2025....
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards
AVITA Medical's RECELL was recognized as the “Best New Technology Solution – Surgical” in the 2025 MedTech Breakthrough Awards. ...
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today
Today: AVITA Medical’s Acute Wound Care Showcase 2025—clinical insights, patient stories, and transformative solutions in acute traumatic wound care....
AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today
See how innovation is transforming patient outcomes through real-world clinical insights and patient stories
AVITA Medical Reports First Quarter 2025 Financial Results
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
AVITA Medical to host Acute Wound Care Showcase 2025 via webcast on May 13, with leadership insights, product highlights, and clinical outcomes....
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
AVITA Medical to Announce First Quarter 2025 Financial Results
AVITA Medical will announce Q1 2025 financial results on May 8, 2025, followed by a conference call and webcast at 1:30 p.m. PT....
AVITA Medical to Announce First Quarter 2025 Financial Results
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
AVITA Medical announced that 16 abstracts will be presented at ABA 2025, featuring real-world and clinical data on RECELL, Cohealyx, and PermeaDerm....
AVITA Medical to Present Breakthrough Clinical Data in Burn and Wound Care at ABA 2025
Sixteen abstracts to present real-world findings and clinical innovations across AVITA Medical’s expanded portfolio, including RECELL, Cohealyx, and PermeaDerm
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
AVITA Medical announces U.S. launch of Cohealyx™, a collagen-based dermal matrix designed to promote tissue integration and revascularization....
AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
AVITA Medical announces new manufacturing agreement and amended distribution agreement with Stedical Scientific to further commercialization of...
AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
AVITA Medical announced that Jim Corbett, CEO, will present at TD Cowen’s 45th Annual Health Care Conference on March 4, 2025, at 11:50 a.m. Eastern Time....
AVITA Medical to Present at TD Cowen’s 45ᵗʰ Annual Health Care Conference
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical invites shareholders and prospective investors to attend its investor webinar briefing and presentation on February 18, 2025 at 2:00PM PT....
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical Reports Fourth Quarter and Full Year 2024 Financial Results
AVITA Medical reported financial results for the fourth quarter and full year 2025....